Clinical Trial Update: A Study to Assess the Effect of Oral Belumosudil on Inhibition of Various Proteins in the Fed State in Healthy Male Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study assessing how oral belumosudil inhibits multiple proteins in the fed state in healthy male volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune System Disorder

Drugs mentioned

• Belumosudil (belumosudil)

Snippet

Sponsor: Kadmon, a Sanofi Company | Conditions: Immune System Disorder, Healthy Volunteers | Phase 1 | Status: COMPLETED